IOVA

NASDAQIovance Biotherapeutics Inc
No tide · 0Squeeze · Watch 56Very Bullish0 buys · $0Social · No data 0
$4.56
$-0.14 (-2.98%)
15-min delayed · Jul 29, 9:10 PMReal-time

Score summary

Strong Buy
Analyst Ratings
6Ratings
5 Buy1 Hold0 Sell
Tide Score
Squeeze Score
56
Watch ·
  • Days to cover5.91
  • Short interest25.75% of float
  • Borrow rate45.22%
  • Utilization100.0%
  • Short interest trend-0.82% (30d)
Trend
Very Bullish
Strong uptrend — 5 of 8 indicators bullish
Recent Smart Money
0 buys
Quiet · $0 · 14d · 5 super investors

Key statistics

Market Cap
$2.23B
52-week range
$1.81 – $5.48
152% from low
Day range
$5 – $5
Open $4.73
Volume
10.7M
vs 15.4M avg · 70%
P/E (TTM)
Fwd —
Earnings
Aug 5
6d · est $-0.13

Country ranks

US RankCountry rank populator pending
BW universe: US & CA common stocks only · ETFs and mutual funds excluded · Methodology →

Price chart with forecast cone and smart-money events

Wall Street Analyst Consensus

Wall Street Analyst Consensus
Aggregate of 6 third-party analyst opinions — not Quantellect advice.
12-mo median price target
$10
6 Wall St 12-month targets
High
$14
Average
$10
Low
$4
$2$5$8$11$14HIGH$14MEDIAN$10LOW$4Jan ’26NOW12-mo target
Recent price history, then Wall-Street analysts’ 12-month price targets (high / median / low) shown forward to the 12-month target levels. Targets are third-party analysts’ estimates of future performance — not guarantees, and not Quantellect recommendations. Past results do not guarantee future returns.
Per-analyst ratings are not yet available for this ticker.
Aggregate of third-party analysts’ published opinions, shown for information only — not Quantellect advice. The 71/100 Analyst Score (Strong Buy) is Quantellect’ documented weighting of the rating distribution on the same 0–100 scale as the Tide / Squeeze / Trend / Money scores; the verdict label is derived from that score. Past results do not guarantee future returns. Source: aes.

Why Tide score breakdown

Smart-money feed

Social pulse

Smart-money modules

Catalysts ahead

Catalysts aheadEarnings Aug 5 (post-market, est EPS $-0.13) · Annual shareholder meeting Jun 17 · Russell 1000 rebalance Jul 22 · DOJ CUDA hearing window Q3

Drill deeper

Not investment advice. Past results do not guarantee future returns. Scores, narratives, and historical-cohort statistics on this page are generated by Quantellect algorithms from public filings, market data, and AI synthesis, and describe the historical performance of structurally similar setups in our universe; failures are included. Data may be 15-minute delayed, contain errors, or be revised. Always do your own research and consult a licensed financial advisor before making investment decisions.